Bekeschus, Sander http://orcid.org/0000-0002-8773-8862
Lippert, Maxi
Diepold, Kristina
Chiosis, Gabriela
Seufferlein, Thomas
Azoitei, Ninel
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (AZ.96/1-3)
Article History
Received: 14 June 2018
Accepted: 20 December 2018
First Online: 11 March 2019
Competing Interests
: Memorial Sloan-Kettering Cancer Center holds the intellectual rights to PU-H71. Samus Therapeutics, of which G. Chiosis has partial ownership, has licensed PU-H71. The corresponding authors are responsible for submitting on behalf of all authors of the paper.